A Truveta study shows that nearly 16 percent of patients prescribed Novo Nordisk’s new weight-loss pill previously used Eli Lilly’s injectable...

A Truveta study shows that nearly 16 percent of patients prescribed Novo Nordisk’s new weight-loss pill previously used Eli Lilly’s injectable...

FAT jabs may help thousands of Brits beat a debilitating skin condition as well as shed the pounds, research suggests. Tirzepatide, the powerful...

MANILA, Feb. 12 (Xinhua) -- The Philippines' total approved foreign investments (FI) surged 79.1 percent year-on-year in the fourth quarter of 2025 to...

MANILA, Feb. 12 (Xinhua) -- The Philippines' total approved foreign investments (FI) surged 79.1 percent year-on-year in the fourth quarter of 2025 to...

Hims and Hers announced a halt in sales of their copy of the weight-loss drug, Wegovy. This decision followed talks with stakeholders. Initially, Hims...

Updated Date: Mon, 09 Feb 2026 00:00:00 EST

Novo Nordisk gained after US firm cancelled competitor to weight-loss drug

Global trade is on course to exceed US$35 trillion in 2025 for the first time, according to the United Nations Trade and Development (UNCTAD)’s...

Eli Lilly's Q4 beat and soaring GLP-1 demand lead top analyst picks, alongside fresh insights on Marriott and Fortinet's latest results.